Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 1997

View Archived Issues

Immunex reports epithelium-derived T-cell factor polypeptides

Kaken describes novel antibacterial agents

Fujisawa reveals antibacterial series

Shin Nippon discloses antiulcer agents

Immunex presents novel cytokine

Osaka University discloses new antigen for the detection of HIV-1

p53 proteins with altered tetramerization domains synthesized

Novel analgesic/antiinflammatory agents from Sanwa Shoyaku

Company Profile: Alizyme

Clinical results reported for Vivus' MUSE

Mentax approved for two new indications by FDA

Improved formulation of Vanceril approved for market

First launch for Sumitomo antidepressant

Joint venture formed to develop cancer therapy

NeoRx technology receives additional patent

ImmuLogic files U.S. IND application for MS therapeutic

Boehringer Mannheim clot-busting drug introduced in first market

ATL technology approaches FDA approval

Gilead files NDA for new cidofovir formulation

Sugen files IND for antipsoriatic agent

Acular approved in U.S. for postoperative ocular inflammation

Oral contraceptive cleared by FDA as acne treatment

P&U discontinues development of agent for DVT; Cytel regains development rights

Regranex update

Amgen, Progenitor sign agreement covering leptin receptor technology

SangStat files for U.S. marketing approval of Thymoglobulin

Kissei, Servier expand licensing agreement for antidiabetic drug

Beta-blockers underused